Ligand profile
CHEMBL4161986
Bioactivity hit from ChEMBL on a similar protein.
Bound to: HT085_RS00030 — leucine--tRNA ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL4161986- UniProt (similar protein)
P07813- pchembl
- 7.840 (~14.5 nM)
- Target protein
- HT085_RS00030
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 141.1
- −1 ≤ LogP ≤ 5 0.90
- MW ≤ 500 Da 363.4
- LogP ≤ 5 0.90
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 141.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(C)C[C@H](N)C(=O)NS(=O)(=O)c1cccc(-c2ccnc(N)n2)c1CC(C)C[C@H](N)C(=O)NS(=O)(=O)c1cccc(-c2ccnc(N)n2)c1
InChI=1S/C16H21N5O3S/c1-10(2)8-13(17)15(22)21-25(23,24)12-5-3-4-11(9-12)14-6-7-19-16(18)20-14/h3-7,9-10,13H,8,17H2,1-2H3,(H,21,22)(H2,18,19,20)/t13-/m0/s1InChI=1S/C16H21N5O3S/c1-10(2)8-13(17)15(22)21-25(23,24)12-5-3-4-11(9-12)14-6-7-19-16(18)20-14/h3-7,9-10,13H,8,17H2,1-2H3,(H,21,22)(H2,18,19,20)/t13-/m0/s1
CUSYDQAXIWAAEA-ZDUSSCGKSA-NCUSYDQAXIWAAEA-ZDUSSCGKSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Curation
- pdb_similarity_tanimoto
- Binding sites
- PF09334
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL4161986 →
- UniProt UniProt P07813 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL4161986”) →
Other ligands for this protein
Quick navigation to other ligands bound to HT085_RS00030.
PDB 21
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 20
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).